News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
181,300 Results
Type
Article (17438)
Company Profile (126)
Press Release (163736)
Section
Business (58191)
Career Advice (938)
Deals (9360)
Drug Delivery (34)
Drug Development (23399)
Employer Resources (70)
FDA (2328)
Job Trends (4221)
News (92173)
Policy (5780)
Tag
Academia (481)
Alliances (16215)
Alzheimer's disease (405)
Antibody-drug conjugate (ADC) (66)
Approvals (2291)
Artificial intelligence (73)
Bankruptcy (78)
Best Places to Work (2880)
Biotechnology (115)
Breast cancer (70)
Cancer (624)
Career advice (755)
CAR-T (71)
Cell therapy (205)
Clinical research (18364)
Collaboration (312)
Compensation (64)
COVID-19 (737)
C-suite (93)
Data (529)
Diabetes (49)
Diagnostics (1051)
Drug discovery (50)
Earnings (15632)
Employer resources (68)
Events (30879)
Executive appointments (275)
FDA (2525)
Funding (269)
Gene therapy (134)
GLP-1 (250)
Government (609)
Healthcare (2378)
Infectious disease (782)
Inflammatory bowel disease (60)
Interviews (136)
IPO (4086)
Job creations (1471)
Job search strategy (701)
Layoffs (143)
Legal (1179)
Lung cancer (74)
Lymphoma (45)
Manufacturing (113)
Medical device (680)
Medtech (681)
Mergers & acquisitions (5404)
Metabolic disorders (181)
Neuroscience (568)
NextGen: Class of 2025 (1440)
Non-profit (450)
Northern California (686)
Obesity (101)
Opinion (167)
Patents (49)
People (21928)
Phase I (7144)
Phase II (8756)
Phase III (4935)
Pipeline (284)
Postmarket research (306)
Preclinical (2899)
Press Release (61)
Radiopharmaceuticals (80)
Rare diseases (134)
Real estate (2433)
Regulatory (4409)
Research institute (518)
Resumes & cover letters (152)
Series A (65)
Southern California (647)
Startups (1779)
United States (5752)
Vaccines (193)
Weight loss (77)
Date
Today (62)
Last 7 days (144)
Last 30 days (746)
Last 365 days (12541)
2025 (701)
2024 (12662)
2023 (13215)
2022 (16075)
2021 (16968)
2020 (13201)
2019 (9496)
2018 (7540)
2017 (8984)
2016 (8120)
2015 (9415)
2014 (9741)
2013 (9463)
2012 (6085)
2011 (6458)
2010 (5859)
Location
Africa (325)
Asia (13370)
Australia (2658)
California (1597)
Canada (573)
China (147)
Connecticut (68)
Europe (29890)
Florida (166)
Illinois (113)
Indiana (85)
Maryland (251)
Massachusetts (1272)
Michigan (66)
Minnesota (105)
New Jersey (429)
New York (406)
North Carolina (295)
Northern California (686)
Ohio (46)
Pennsylvania (342)
South America (406)
Southern California (647)
Texas (183)
Washington State (277)
181,300 Results for "miltenyi biotec".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
MiLaboratories and Miltenyi Biotec Announce Strategic Partnership to Advance Next Generation Therapies
MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that promises to revolutionize the field of next-generation therapies.
April 29, 2024
·
3 min read
Deals
Miltenyi Biotec acquires biosensor company lino Biotech
lino Biotech announced it has been acquired by Miltenyi Biotec, a global biotech company based in Germany, on February 22, 2023.
March 15, 2023
·
2 min read
Pharm Country
Cell BioEngines Enters Agreement with Miltenyi Bioindustry to Manufacture Hematopoietic Cell Therapy Clinical Program
Cell BioEngines, Inc. announced an agreement with Miltenyi to develop and manufacture its expanded hematopoietic stem cell transplantation product for clinical use in hematology-oncology.
December 29, 2023
·
3 min read
Business
Replay’s oncology-focused product company Syena and Miltenyi Biotec enter into exclusive licensing and GMP manufacturing agreement for PRAME TCR-NK cell therapy based on CliniMACS Prodigy®
Replay today announced a licensing and manufacturing agreement to support the development of a GMP-compliant T-cell receptor (TCR) natural killer (NK) cell therapy targeting the tumor-associated neoantigen, PRAME.
December 18, 2023
·
5 min read
Miltenyi Biotec launches world’s first fully automated light sheet microscope
Miltenyi Biotec today announces the UltraMicroscope Blaze.
August 11, 2020
·
3 min read
Miltenyi Biotec offers automated and closed adherent cell culture solutions on CliniMACS Prodigy®
Miltenyi Biotec announced the immediate availability of its new CliniMACS Prodigy® Adherent Cell Culture System.
August 11, 2020
·
3 min read
Miltenyi Biotec launches new tool for coronavirus-specific T cell research
Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19.
August 11, 2020
·
3 min read
Deals
Veranex Acquires Fusion Biotec to Continue Accelerating MedTech Diagnostic Solutions
Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the MedTech industry, announced today that it has acquired Fusion Biotec (Fusion), a design and engineering leader for complex electro-mechanical diagnostic instrumentation and medical devices located in Orange, California.
December 13, 2022
·
3 min read
Pharm Country
BD, CerTest Biotec Announce Emergency Use Authorization for Mpox Diagnostic Test
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and CerTest Biotec have announced Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a molecular polymerase chain reaction (PCR) assay for Mpox virus detection.
January 9, 2023
·
4 min read
Business
Purigen Biosystems Signs Exclusive Agreement with Bucher Biotec AG to Strengthen Commercial Presence in the European Union
Purigen Biosystems, Inc. today announced a new distribution agreement with Bucher Biotec AG.
September 20, 2022
·
3 min read
1 of 18,130
Next
